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g.2013.1Abstract Background: Rare autosomal recessive disorders of variable severity are segregating in
many highly consanguineous families from the Arab population. One of these deleterious diseases
is Senior-Loken syndrome, a hereditary heterogeneous multiorgan disorder, which combines neph-
ronophthisis with retinal dystrophy, leading to blindness and eventually end stage renal failure. This
disorder has been reported in many cases worldwide, including two unrelated families from Arabian
Gulf countries, which share the gene pool with Kuwait.
Case report: Here, we are reporting two children from an Arab family with a novel frameshift
mutation found in IQCB1/NPHP5 gene; c.1241-1242delTC, predicted to cause protein termination
p.Leu414HisfsStop4, and describing the associated clinical features.
Conclusion: Identiﬁcation of this pathogenic mutation helped in conﬁrmation of the clinical
diagnosis and in providing a proper pre-marital genetic counselling and testing for a couple
embarking on marriage from this highly consanguineous high-risk family.
 2013 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Senior-Loken (S-L) is an autosomal recessive syndrome and a
variant of the nephronophthisis-associated disorders, infailure; S-L, Senior-Loken;
urea nitrogen
814328; fax: +965 24842073.
com (M.J Maraﬁe), fahd@
Shams University.
g by Elsevier
ng by Elsevier B.V. on behalf of A
2.003which the cystic kidney disease is associated with retinal
dystrophy (retinitis pigmentosa or Leber congenital amauro-
sis). It is a deleterious disease that culminates in blindness
and renal failure. Visual prognosis is usually poor and no
deﬁnite treatment is available to date. However, renal trans-
plantation appears to be the best option for the end stage re-
nal failure (ESRF) [1–5]. This clinical association was
described for the ﬁrst time in 1961, in many patients and
by two authors separately [1,2]. Consequently, more cases
have been reported worldwide [6–8], including affected indi-
viduals in two separate unrelated families from Qatar and
Saudi Arabia [9,10], being two Arabian Gulf countries, with
a population that share the gene pool with the Arab popula-
tion of Kuwait.in Shams University.
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Figure 1 Family pedigree. The proband is indicated by an
arrow. The couples embarking on marriage are indicated by the
star signs.
204 M.J Maraﬁe, F. Al-MullaNephronophthisis (NPHP), a heterogeneous ciliary dys-
function, or as named renal ciliopathy, is a disease causing cys-
tic kidneys or renal cystic dysplasia, and the most common
genetic cause of chronic renal failure in the ﬁrst two decades
of life [11–13]. Three clinical variants have been recognised;
infantile, juvenile and adolescent types, depending on the age
of onset of the manifestations and on the causative genes.
The median age of onset varied, being 1, 13 and 19 years
respectively [13,14]. The juvenile variant is the most common
form of NPHP, it constitutes 5–10% of ESRF in affected chil-
dren [15]. Furthermore, NPHP is frequently associated with a
broad spectrum of extra-renal manifestations, constituting dif-
ferent clinico-pathological disorders, depending on the type of
the mutated genes. Hence, molecular analysis of the relevant
gene is important for conﬁrmation of the clinical diagnosis
and for providing effective genetic counselling.
A variety of ciliopathy disorders, other than Senior-Loken
syndrome, have been described; including Bardet–Biedl syn-
drome (obesity, hypogonadism, retinal degeneration, polydac-
tyly, mental retardation, and renal malformations), Jeune
asphyxiating thoracic dystrophy (a lethal skeletal dysplasia
condition with shortening of the bones and a narrow thorax),
Joubert syndrome (cerebellar vermis hypoplasia and brainstem
abnormalities; the primary hallmark is the molar tooth sign in
the brain), Meckel–Gruber syndrome (a lethal disorder with
occipital meningoencephalocele, cystic kidneys, hepatic devel-
opmental defect, post axial polydactyly, shortening and bow-
ing of long tubular bones, congenital heart defects,
microphthalmia, and cleft lip/palate), and Sensenbrenner syn-
drome or cranioectodermal dysplasia (retinal degeneration
hepatobiliary disease, cerebellar vermis hypoplasia, and short-
ening of long bones in combination with craniosynostosis and
ectodermal dysplasia such as skin laxity and abnormal denti-
tion) [12,16,17].
To date, pathogenic mutations in at least 14 different
NPHP genes have been identiﬁed, (named nephrocystin genes)
including (NPHP1, INV/NPHP2, NPHP3, NPHP4, IQCB1/
NPHP5, CEP260/NPHP6, GLIS2/NPHP7, RPGRIP1L/
NPHP8 and NEK8/NPHP9, SDCCAG8/NPHP10,
TMEM67/NPHP11, TTC21B/NPHP12, WDR19/NPHP13,
and XPNPEP3/NPHPL1) [3,4,14,16–21]. These genes encode
the cilia-associated proteins (nephrocystins) that form supra-
molecular complexes essential for cilia formation and its regu-
latory function in many organs; including retina, inner ear,
kidney and brain. In general, all these identiﬁed genes explain
the disease in only 30% of the affected patients, with NPHP1
being responsible for 20% of the genetically studied cases [13].
Nevertheless, further potential genes are expected to be discov-
ered due to the enormous clinico-genetic (phenotype-genotype)
heterogeneity of the disease that has a marked inﬂuence on its
presentation and severity, and the massive phenotypic overlap
that results in emerging of many syndromes [12,16]. Mutations
in the IQCB1/NPHP5 (SLN5/OMIM; 609237, on chromo-
some 3q21) are reported to be the most frequent causes of S-
L syndrome [4], with a phenotypic variation between carriers
of different mutations along the same gene [22,23]. We have
investigated an Arab family from Kuwait having two children
affected with S-L syndrome. Molecular analysis revealed a no-
vel IQCB1/NPHP5 gene mutation that we report for the ﬁrst
time. Identiﬁcation of the causative gene mutation conﬁrmed
the clinical diagnosis and encouraged other family members
to seek genetic counselling and testing.2. Family data
The family presented here constitutes ﬁrst cousin parents and
ﬁve children, two of whom were affected with the S-L disorder.
There was no family history of any hereditary disease such as
renal, visual or hearing defect. Two more family members (a
couple) embarking on marriage, approached the clinic for ge-
netic counselling and testing, one being a female ﬁrst cousin of
the proband, and the second being a male ﬁrst cousin of his
father (Fig. 1).
2.1. Patient 1
The proband with a clinical diagnosis of nephronophthisis,
congenital blindness and ESRF, was referred to the genetics
clinic at the age of 9 years for genetic counselling and conﬁrm-
ing the diagnosis of S-L syndrome by molecular analysis to
avoid renal biopsy. At that time, he was on peritoneal dialysis,
for few months, for his ESRF secondary to his condition. He
was the product of full term pregnancy and normal delivery,
with normal developmental milestones. He was blind since
birth, with a high frequency nystagmus, and was diagnosed
with Leber’s congenital amaurosis at the age of 8 months.
He was on regular follow up by a nephrologist since early life,
where the renal function test, serum electrolytes and urine
analysis were performed periodically because of the family his-
tory of a similar condition in his elder sister. At the age of
8 years, he looked well, with normal intellectual ability, but
1 year delayed bone age. His body weight was 24 kg, and
height was 118 cm (25th percentile). Abdominal and pelvic
ultrasound of all organs was normal, except for kidneys. Both
kidneys were of normal size, but with increased echotexture,
more pronounced on the right side. The right kidney measured
8.2 cm and the left one was 8.1 cm. The bladder was unremark-
able. These ﬁndings were suggestive of early changes of
chronic kidney disease. All other investigations were normal
such as eye and brain CT scan. A few months later, his inves-
tigations showed Urea Nitrogen blood (BUN) of 27 mmol/L,
serum creatinine of 547 lmol/L, serum calcium of 4.09 mm/l
and phosphorus of 0.56 mmol/L. Unfortunately, his condition
deteriorated rapidly; his renal function was impaired, having
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tension, which then progressed to ESRD in a very short peri-
od. Initially, he was managed with standard medical anti
failure treatment and dialysis, then underwent pre-emptive
cadaveric renal transplant few months later.
2.2. Patient 2
His sister was 18 years old at the time of the counselling visit.
She was born at full term after an uneventful pregnancy, by
normal vaginal delivery. Her general condition was good with
normal developmental milestones. Her parents noticed her
poor vision at the age of 3 months. Eye examination at the
age of 22 months revealed a very poor eye ﬁxation with a high
frequency nystagmus, hypermetropic vision (+8.0) and nor-
mal fundi. Retinoscopy of both eyes indicated severe retinal
dysfunction, with an evidence of rudimentary activation of
post retinal pathway. The electrodiagnostic picture was sugges-
tive of Leber congenital amaurosis as it showed low amplitude
scotopic and photopic response. All other investigations
including brain and eye CT scan were normal. There was no
history of polyuria, polydipsia, urinary tract infection or
change in urine colour in her childhood and was normotensive.
Her intellectual abilities were within normal. At the age of
13 years, her height was 131 cm and the weight was 31 kg,
which were signiﬁcantly below the ﬁfth percentile for her
age. She described periods of pain and tingling of ﬁngers with
dysuria. Her urine analysis showed excess white cells, but urine
culture was negative. The level of urea nitrogen blood (BUN)
was 19 mmol/L and creatinine 379 lmol/L. Her condition
deteriorated, further investigations showed deterioration of
the renal function, as her serum creatinine was >500 lmol/Figure 2 Electropherogram of the homozygous mutation c.1241-1242
his relatives. (A) Wild type (B) homozygous carrier. (C) HeterozygousL, and BUN was 25 mmol/L. She also had severe hypocalca-
emia (1.7 mmol/L), which explained her tingling and pain sen-
sations in the ﬁngers, the carpopedal spasm, and renal
osteodystrophy. Complete blood cell count showed microcytic,
hypochromic anaemia (Hb 7 g/L). Also, the biochemistry test
revealed mild hypophosphatemia, hypomagnesaemia, but nor-
mal electrolytes. Other biochemical and haematological indices
were within the normal limits. Renal ultrasound showed hy-
per-echogenic renal parenchyma, poor cortico-medullary dif-
ferentiation, but normal sized kidneys. There was a
medullary cyst of 1.3 cm was located in the right kidney.
Roentgenograms of both hands showed generalised osteope-
nia, widening of epiphysis, irregular metaphyseal surface, ero-
sion of diaphysis of ulnar bones and delayed bone age, which
was corresponding to 11.5 years. Her condition then rapidly
progressed to the ESRF. One month later, she underwent
pre-emptive cadaveric renal transplant. However, she devel-
oped post-transplant diabetes mellitus.
3. Methods and results
The written informed consent was obtained from the parents
and their adult relatives for blood collection and molecular
testing. The genomic DNA was extracted from the peripheral
blood for deﬁning the carrier status of the involved subjects.
Sequence analysis of the entire coding region of the IQCB1/
NPHP5 gene was performed as described previously [22] and
showed that the proband and his affected sister were
homozygous carriers for the c.1241-1242delTC in exon 12 of
the gene (Fig. 2). We conﬁrmed the mutation in the proband
and family members using the same standard sequencing pro-
tocol, which utilised the following forward and reverse primersdelTC, exon 12 of IQCB1/NPHP5 gene found in the proband and
carrier showing the frameshift.
206 M.J Maraﬁe, F. Al-Mullarespectively: F-50- GCATGGCAGTGAGTATGTTGT-30 and
R-50- AGGCTCAAGAAAACTAAGTGTCT-30. The muta-
tion (p.leu414HisfsStop4) is predicted to be pathogenic be-
cause it leads to protein truncation. Both parents and two
other sibs were proved to be heterozygous carriers for the same
mutation, while one brother was found normal. The proband’s
cousin was also heterozygous carrier for the same mutation,
while her ﬁance´ was normal (Fig. 1).
4. Discussion
S-L syndrome is a rare entity that has been reported in many
families worldwide [6–8], including two different Arab families
from Qatar and Saudi Arabia [9,10]. Here, we have investi-
gated an Arab family with two children affected with S-L syn-
drome. A novel mutation in exon 12 of IQCB1/NPHP5 gene
was identiﬁed; named c.1241-1242delTC, which is predicted
to result in a premature protein truncation (p.leu414Hisfs-
Stop4). The gene has been termed the classical S-L gene be-
cause its mutations have been only associated with renal-
retinal phenotype [5]. Indeed, our affected family members
showed diseases limited to the retina and kidney, albeit to a
different extent. Previous work reported several mutations in
the IQCB1/NPHP5 gene [7,22,24]. However, to the best of
our knowledge, this mutation has not been reported previ-
ously. Moreover, this is the ﬁrst report of IQCB1/NPHP5 gene
mutation found in the Arabian Peninsula. The implication of
this ﬁnding was discussed with the family members, who were
cooperative and understanding of the preventive measures
against recurrence of the disease in their future generations;
hence a related couple approached the clinic requesting pre-
marital genetic testing.
The prevalence of consanguineous marriages is high in the
Arab population and it reached 54.3% in Kuwait, with esti-
mated population incidence rates of 52.9–55.7% [25–27]. Con-
sequently increasing the incidence of autosomal recessive
diseases, some of which are very rare and their causative gene
mutations have never been identiﬁed. For thousands of years,
intra-familial and intra-tribal marriages are most traditionally
practised; this creates the need for a proper premarital man-
agement of couples embarking on marriage, from families with
hereditary diseases, and hence molecular screening should be
provided to them as a preventive measure against recurrence
in their future generations. There is a need for documentation
of the mutations detected in all unfortunate families with rare
diseases, which are scattered in the Arab world and Middle
East to help clinicians provide well-tailored genetic counselling
and reasonably priced molecular tests. The parental educa-
tional background, their cooperation and the gene mutation,
which was identiﬁed in the proband and his relatives, further
enhanced management of this family.
5. Conclusion
We have identiﬁed a novel pathogenic gene mutation in a
highly consanguineous high-risk family with a rare devastating
autosomal recessive disease. This ﬁnding has its serous impli-
cation for the future generations in case of intermarriages
amongst the family members. Therefore, we used this informa-
tion to guide us in providing a proper premarital genetic coun-
selling. There is a need to educate the public and the clinicianswho are involved in providing the premarital genetic service, as
the mandatory genetic screening covers only few common
blood disorders. Hence the consanguineous couples should
be referred to the genetic clinic if such diseases were found seg-
regating within their families.
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